Clinical Trials on Anti-Retroviral Agents in Sweden
Total 27 results
-
Annelies VerbonUniversity Hospital, Geneva; Erasmus Medical Center; Uppsala University Hospital and other collaboratorsUnknownMobile Applications | Quality Improvement | Anti-Infective Agents | Antimicrobial StewardshipCanada, Netherlands, Sweden, Switzerland
-
Linkoeping UniversityCompletedPregnancy | Pharmacokinetics | Antidepressive AgentsSweden
-
Örebro University, SwedenCompletedPCI | Coronary StentsSweden
-
Mårten SegelmarkHansa Biopharma ABCompletedAnti-Glomerular Basement Membrane Antibody DiseaseAustria, Czechia, Denmark, France, Sweden
-
Ostergotland County Council, SwedenRecruitingStress | Child Development | Breastfeeding | Adverse Events | BondingSweden
-
Region SkaneLund UniversityCompleted
-
Karolinska InstitutetCompletedWomen With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2Sweden
-
Uppsala UniversityCompleted
-
Region VästmanlandTerminatedRectal Cancer | Other Diagnoses, Comorbidities, and Complications | Sphincter Ani IncontinenceSweden
-
Uppsala University HospitalSwedish Heart Lung Foundation; Advanz PharmaCompleted
-
Lund UniversityRegion Skane; ForteCompleted
-
Nippon Kayaku Co., Ltd.CompletedWegener's GranulomatosisUnited Kingdom, Germany, Sweden, Czech Republic, Denmark, Netherlands
-
Karolinska InstitutetAarhus University Hospital; Rigshospitalet, Denmark; Linkoeping University; Aalborg... and other collaboratorsCompletedCOVID-19 | Bleeding | Thrombosis EmbolismSweden
-
Karolinska InstitutetCompletedCovid-19 | Bleeding | Thromboembolic EventsSweden
-
Karolinska InstitutetRegion Stockholm; Forte; Stiftelsen Frimurarna BarnhusetActive, not recruitingDepression | Stress, Psychological | Intellectual Disability | Anxiety | Neurodevelopmental Disorders | Traumatic Brain Injury | Autism Spectrum Disorder | Parents | Attention Deficit Hyperactivity Disorder | Physical DisabilitySweden
-
PfizerCompletedDiabetic Retinopathy | Diabetic Macular Edema | Anti- VGF InhibitorSpain, United Kingdom, Finland, Sweden
-
Hansa Biopharma ABRecruitingAnti-Glomerular Basement Membrane Disease | Goodpasture Syndrome | Anti-Glomerular Basement Membrane Antibody Disease | Good Pasture SyndromeUnited States, Netherlands, Spain, Sweden, United Kingdom, Czechia, Germany, Italy, France, Denmark
-
AstraZenecaTerminatedThromboembolismSweden, France, Mexico, Poland, South Africa, Spain, Germany, Hungary, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Switzerland
-
Novartis PharmaceuticalsTerminatedCardiovascular EventsColombia, India, South Africa, Canada, Spain, Hungary, United States, Germany, Ireland, Argentina, Philippines, Brazil, Sweden, Malaysia, Chile, Israel, Czech Republic, Netherlands
-
ChemoCentryxCompletedA Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (ADVOCATE)ANCA-Associated VasculitisUnited States, Australia, Belgium, Canada, France, Italy, Japan, Netherlands, Spain, United Kingdom, Austria, Czechia, Denmark, Germany, Hungary, Ireland, New Zealand, Norway, Sweden, Switzerland
-
Human Genome Sciences Inc., a GSK CompanyGlaxoSmithKlineCompletedVasculitisUnited States, Australia, France, Spain, Italy, Peru, Belgium, Canada, Germany, Romania, Mexico, United Kingdom, Hungary, Ireland, Poland, Switzerland, Czechia, Russian Federation, Norway, Sweden
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Pennsylvania; Roche Pharma AG; Genentech, Inc.; Arthritis Research...CompletedMicroscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Wegener GranulomatosisUnited States, Canada, United Kingdom, Sweden, New Zealand, Ireland, Australia, Italy, Czechia, Japan
-
InflaRx GmbHCompletedGranulomatosis With Polyangiitis (GPA) | Microscopic Polyangiitis (MPA)Germany, Russian Federation, Belgium, France, Spain, Czechia, Italy, Netherlands, Sweden, Switzerland, United Kingdom
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedMicroscopic Polyangiitis (MPA) | Granulomatosis With Polyangiitis (Wegener's) (GPA)United States, Belgium, France, United Kingdom, Denmark, Canada, Japan, Australia, New Zealand, Sweden, Czechia, Italy, Greece, Mexico, Norway
-
SanofiTerminatedAtrial FibrillationSouth Africa, Thailand, Chile, Guatemala, Ukraine, United States, Argentina, Australia, Austria, Belarus, Brazil, Bulgaria, Canada, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Greece, India, ... and more
-
GlaxoSmithKlineRecruitingEosinophilic Granulomatosis With PolyangiitisCanada, France, Italy, Spain, Belgium, Korea, Republic of, United States, Japan, China, Czechia, Hungary, Israel, Portugal, Poland, Netherlands, United Kingdom, Austria, Argentina, Australia, Brazil, Germany, Sweden
-
University of OxfordAmerican College of Rheumatology; The European League Against Rheumatism (EULAR) and other collaboratorsUnknownGiant Cell Arteritis | Wegener's Granulomatosis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu Arteritis | Churg Strauss SyndromeKorea, Republic of, United States, Germany, Australia, Japan, Ireland, Belgium, Italy, Denmark, Slovenia, Switzerland, Canada, Argentina, Austria, China, Czech Republic, Egypt, Finland, France, Hungary, India, Mexico, Netherlands, New... and more